The regular consumption of very small doses of psychedelic drugs (known as microdosing) has been a source of growing media and community attention in recent years. However, there is currently limited clinical and social research evidence on the potential role of microdosing as therapies for mental and substance use disorders. This paper examined subjective experiences of microdosing...
BackgroundIn recent years there has been growing media attention on microdosing psychedelics (e.g., LSD, psilocybin). This refers to people routinely taking small doses of psychedelic substances to improve mental health and wellbeing, or to enhance cognitive performance. Research evidence is currently limited. This paper examines microdosing motivations, dosing practices, perceived short-term...
BMC Public HealthMay 14, 2019Diana Moesgen, Katharina Ise, Janina Dyba et al.
Abstract Background Children of substance-abusing parents are at a substantial risk of developing substance-use and other mental disorders. Children involved in substance abuse – not diagnosed with substance-use problems but integrated in psychiatric treatment or youth welfare services – constitute a particular high-risk group that is in need of substance use prevention. Emerging evidence...
In recent years, there is renewed interest in the study of various hallucinogens for their potential therapeutic effects. In the United States of America (USA), the abuse potential assessment of a drug is carried out as part of the general safety and efficacy evaluation of a drug. Additionally, the abuse potential assessment is taken under consideration in determining if a drug needs to be...